BU BÖLÜM HAKKINDA
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit bias, this app is being developed to help patients overcome communication barriers, data silos, and the imbalance of power between the patient and medical professionals. Addressing the social determinants of health SDOH is top of mind in the improvement of population health particularly in the age of COVID-19.
@patientorator #patientdata #populationhealth #precisionhealth #socialdeterminantsofhealth #SDOH #healthcaredata #COVID19
ingilizce
Amerika Birleşik Devletleri
SON BÖLÜMLERİ ARA
Empowered Patient Podcast için geçmiş bölümleri ara.
BU PODCAST'IN DİĞER BÖLÜMLERİ
Leo Petrossian, CEO of Kandu, discusses a groundbreaking approach to stroke recovery that uses an FDA-cleared, non-invasive EEG headset combined with a robotic glove that detects when a patient visualizes moving their impaired arm and simultaneously moves the arm mechanically. Traditional rehabili…
Steve Beard, CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are m…
Steve Beard, CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are m…
Dr. John Friend, CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering …
Dr. John Friend, CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering …
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Karen Jagoda'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
